What is ORKA's dilution risk score?

ORKA has a latest available DilutionScore record of 45/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ORKA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ORKA?

DilutionWatch tracks 25 SEC filing types for ORKA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ORKA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ORKA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ORKA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ORKA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ORKA Dilution Risk Score: 45/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

85

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 19%

💰 Capital Raise model 38%

• Active shelf registration ($1000M, 28% of market cap)

• Active ATM program with $700M remaining capacity

🔔 Track ORKA — Get forecast alerts →

Market Data

Market Cap$3.53B

Shares Outstanding66.21M

Float51.05M

Cash$873.56M

Debt$1.81M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 15.1% shares (2026Q1 vs prior)

188 institutional holders · 61.09M shares

#1 FMR LLC 7.43M shares

#2 Venrock Adviser, LLC 4.15M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 3.72M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.05M

Days to Cover8.4

% of Float15.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2024-12-31

Form 4 INSIDER TRANSACTION 2026-08-24

Form 4 INSIDER TRANSACTION 2026-08-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ORKA Dilution Snapshot

Oruka Therapeutics, Inc. (ORKA) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $1.00B.
Stored ATM program remaining capacity: $700.4M.
Stored outstanding warrants: 315,356.
Recent SEC activity tracked for ORKA: Form 4 on 2026-08-24; Form 4 on 2026-08-24; Form 4 on 2026-08-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.